Skip to main content
Addgene

pCMV-ABEmax-NRTH
(Plasmid #136922)

Print

Ordering

This material is available to academics and nonprofits only.
Item Catalog # Description Quantity Price (USD)
Plasmid 136922 Standard format: Plasmid sent in bacteria as agar stab 1 $85
Add to Cart

Backbone

  • Vector backbone
    pBR322 CMV
  • Vector type
    Mammalian Expression, CRISPR

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin, 100 μg/mL
  • Growth Temperature
    37°C
  • Growth Strain(s)
    Mach1
  • Copy number
    High Copy

Gene/Insert

  • Gene/Insert name
    ABEmax-NRTH
  • Species
    Synthetic; APOBEC1 is from rat (synthetic gene block, mammalian codon optimized), Cas9 is S. pyogenes (mammalian codon optimized)
  • Mutation
    see manuscript
  • Promoter CMV

Cloning Information

  • Cloning method Ligation Independent Cloning

Resource Information

Terms and Licenses

  • Academic/Nonprofit Terms
  • Industry Terms
    • Not Available to Industry
Trademarks:
  • Zeocin® is an InvivoGen trademark.

Depositor Comments

Insert has leaky expression during bacterial propagation and can result in a higher than expected spontaneous mutation rate. The insert should always be sequence validated before use.

How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    pCMV-ABEmax-NRTH was a gift from David Liu (Addgene plasmid # 136922 ; http://n2t.net/addgene:136922 ; RRID:Addgene_136922)

  • For your References section:

    Continuous evolution of SpCas9 variants compatible with non-G PAMs. Miller SM, Wang T, Randolph PB, Arbab M, Shen MW, Huang TP, Matuszek Z, Newby GA, Rees HA, Liu DR. Nat Biotechnol. 2020 Apr;38(4):471-481. doi: 10.1038/s41587-020-0412-8. Epub 2020 Feb 10. 10.1038/s41587-020-0412-8 PubMed 32042170
Related items:
Commonly requested with: